Goldstone Financial Group, LLC Pfizer Inc Transaction History

Goldstone Financial Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jan 15, 2025	SELL	$25.89 - $29.73 $25,501 - $29,284	-985 Reduced 10.45%	8,445 $234 Million
Q4 2023 Jan 15, 2025	BUY	$26.13 - $33.94 $60,882 - $79,080	2,330 Added 32.82%	9,430 $271 Million
Q3 2023 Jan 15, 2025	SELL	$32.09 - $37.51 $22,206 - $25,956	-692 Reduced 8.88%	7,100 $236 Million
Q2 2023 Jan 15, 2025	BUY	$36.12 - $41.79 $34,891 - $40,369	966 Added 14.15%	7,792 $286 Million
Q1 2023 Jan 15, 2025	BUY	$39.39 - $51.28 $268,876 - $350,037	6,826 New	6,826 $278 Million

3,228

3.62B

77.1M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Goldstone Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Goldstone Financial Group, LLC with notifications on news.